FDA Issues Warning on Cox-2 Inhibitors and NSAIDs
The FDA announced today that they are requiring a boxed warning be placed on all Non-Steroidal Anti-inflammatory Drugs (NSAIDs) including all Cox-2 inhibitors. The warning notifies patients of cardiovascular and gastrointestinal risks. The FDA warning includes popular over-the-counter NSAIDs, such as Aleve, Advil and Motrin.
This warning comes with little surprise, as indictors of a cardiovascular risk for NSAIDs have been around for years. The concern is that these warnings are too little too late.
Post A Comment / Question